Millennium Management LLC Buys 104,264 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Millennium Management LLC grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 327.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 136,070 shares of the medical instruments supplier’s stock after buying an additional 104,264 shares during the quarter. Millennium Management LLC owned 0.56% of ICU Medical worth $16,158,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in ICU Medical by 14.8% during the fourth quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier’s stock valued at $243,438,000 after purchasing an additional 315,103 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of ICU Medical by 539.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 177,009 shares of the medical instruments supplier’s stock valued at $17,655,000 after buying an additional 149,313 shares in the last quarter. Silvercrest Asset Management Group LLC raised its holdings in shares of ICU Medical by 109.4% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock valued at $29,882,000 after buying an additional 145,485 shares in the last quarter. Mesirow Institutional Investment Management Inc. bought a new stake in ICU Medical in the 1st quarter worth approximately $15,425,000. Finally, Victory Capital Management Inc. boosted its stake in ICU Medical by 2,966.3% in the second quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock worth $16,844,000 after buying an additional 137,222 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ICUI. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. Raymond James boosted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. KeyCorp upped their price target on shares of ICU Medical from $136.00 to $147.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $149.00.

ICU Medical Stock Up 1.3 %

Shares of NASDAQ ICUI opened at $179.20 on Friday. The company has a market cap of $4.37 billion, a price-to-earnings ratio of -73.14 and a beta of 0.66. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The firm’s fifty day moving average is $160.16 and its 200 day moving average is $126.62. ICU Medical, Inc. has a 52 week low of $78.28 and a 52 week high of $188.53.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.56. The firm had revenue of $596.50 million for the quarter, compared to analysts’ expectations of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.58 earnings per share. On average, equities research analysts expect that ICU Medical, Inc. will post 3.76 earnings per share for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,050 shares of the stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the sale, the vice president now owns 4,482 shares in the company, valued at approximately $645,901.02. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, VP Virginia Ruth Sanzone sold 2,050 shares of the company’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares in the company, valued at $645,901.02. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $18,665,666.78. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,552 shares of company stock worth $6,679,322 in the last 90 days. Company insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.